Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis
Authors
Keywords
-
Journal
Journal of Translational Medicine
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-07-06
DOI
10.1186/s12967-022-03511-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic Targeting of DNA Damage Response in Cancer
- (2022) Wonyoung Choi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors
- (2022) Saiama N. Waqar et al. INVESTIGATIONAL NEW DRUGS
- The role of Exosomal miRNAs in cancer
- (2022) Chuanyun Li et al. Journal of Translational Medicine
- Clinical validation of a 90-gene expression test for tumor tissue of origin diagnosis: a large-scale multicenter study of 1417 patients
- (2022) Wei Sun et al. Journal of Translational Medicine
- Clinical Epigenetics of Neuroendocrine Tumors: The Road Ahead
- (2021) Annamaria Colao et al. Frontiers in Endocrinology
- Nerve growth factor interacts with CHRM4 and promotes neuroendocrine differentiation of prostate cancer and castration resistance
- (2021) Wei-Yu Chen et al. Communications Biology
- The Role of Serum 5-HIAA as a Predictor of Progression and an Alternative to 24-h Urine 5-HIAA in Well-Differentiated Neuroendocrine Neoplasms
- (2021) Maria Wedin et al. Biology-Basel
- Identification of Novel Fusion Transcripts in High Grade Serous Ovarian Cancer
- (2021) Andreea Newtson et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma
- (2021) Akihiro Ohmoto et al. MODERN PATHOLOGY
- Prevalence of TP-53/Rb-1 Co-Mutation in Large Cell Neuroendocrine Carcinoma
- (2021) Hoda Saghaeiannejad Esfahani et al. Frontiers in Oncology
- New Synthetic Lethality Re-Sensitizing Platinum-Refractory Cancer Cells to Cisplatin In Vitro: The Rationale to Co-Use PARP and ATM Inhibitors
- (2021) Watson P. Folk et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets
- (2021) Chandra K. Maharjan et al. Cancers
- A phase II trial of everolimus in patients with advanced pancreatic neuroendocrine carcinoma refractory or intolerant to platinum-containing chemotherapy (NECTOR trial)
- (2020) Hiroyuki Okuyama et al. NEUROENDOCRINOLOGY
- ATM, ATR and DNA-PKcs kinases—the lessons from the mouse models: inhibition ≠ deletion
- (2020) Demis Menolfi et al. Cell and Bioscience
- Molecular subtyping in pancreatic neuroendocrine neoplasms: New insights into clinical, pathological unmet needs and challenges
- (2020) Jie Yan et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Roles for MDC1 in cancer development and treatment
- (2020) Sophie Ruff et al. DNA REPAIR
- Altered miRNAs Expression Correlates With Gastroenteropancreatic Neuroendocrine Tumors Grades
- (2020) Elisabetta Cavalcanti et al. Frontiers in Oncology
- Role of tissue and circulating microRNA and DNA as biomarkers in medullary thyroid cancer
- (2020) Martina Chiacchiarini et al. PHARMACOLOGY & THERAPEUTICS
- The 2019 WHO classification of tumours of the digestive system
- (2019) Iris D. Nagtegaal et al. HISTOPATHOLOGY
- A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (CC-223) for non-pancreatic neuroendocrine tumors with or without carcinoid symptoms
- (2019) Edward Wolin et al. PLoS One
- Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patients
- (2018) Paola Romeo et al. ENDOCRINE-RELATED CANCER
- Evaluating gastroenteropancreatic neuroendocrine tumors through microRNA sequencing
- (2018) Nicole Panarelli et al. ENDOCRINE-RELATED CANCER
- Evaluation of miRNAs expression in medullary thyroid carcinoma tissue samples: miR-34a and miR-144 as promising overexpressed markers in MTC
- (2018) Noushin Shabani et al. HUMAN PATHOLOGY
- The Identification of Potent, Selective, and Orally Available Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase: The Discovery of AZD0156 (8-{6-[3-(Dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro-2H-pyran-4-yl)-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one)
- (2018) Kurt G. Pike et al. JOURNAL OF MEDICINAL CHEMISTRY
- The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models
- (2018) Stephen T. Durant et al. Science Advances
- Molecular Genetic Studies of Pancreatic Neuroendocrine Tumors
- (2018) Mark Stevenson et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal
- (2018) Guido Rindi et al. MODERN PATHOLOGY
- miRWalk: An online resource for prediction of microRNA binding sites
- (2018) Carsten Sticht et al. PLoS One
- Gastroenteropancreatic Neuroendocrine Tumors
- (2018) Mauro Cives et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Maftools: efficient and comprehensive analysis of somatic variants in cancer
- (2018) Anand Mayakonda et al. GENOME RESEARCH
- The safety of available treatments options for neuroendocrine tumors
- (2017) A. Faggiano et al. Expert Opinion On Drug Safety
- Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas
- (2017) Moritz Jesinghaus et al. MODERN PATHOLOGY
- Whole-genome landscape of pancreatic neuroendocrine tumours
- (2017) Aldo Scarpa et al. NATURE
- Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading
- (2017) Elisabetta Cavalcanti et al. Cell Death & Disease
- Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas
- (2017) Bryan Oronsky et al. NEOPLASIA
- Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
- (2017) Arvind Dasari et al. JAMA Oncology
- Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensus
- (2016) Simron Singh et al. CANCER TREATMENT REVIEWS
- Pathologic Classification of Neuroendocrine Neoplasms
- (2016) David S. Klimstra HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Metronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinoma
- (2016) C. De Divitiis et al. Journal of Translational Medicine
- Next-generation sequencing in thyroid cancer
- (2016) Yoon Jin Cha et al. Journal of Translational Medicine
- Efficacy and Safety of Everolimus in Extrapancreatic Neuroendocrine Tumor: A Comprehensive Review of Literature
- (2016) Antongiulio Faggiano et al. ONCOLOGIST
- Management of advanced medullary thyroid cancer
- (2016) Julien Hadoux et al. Lancet Diabetes & Endocrinology
- GOplot: an R package for visually combining expression data with functional analysis: Fig. 1.
- (2015) Wencke Walter et al. BIOINFORMATICS
- Expression Pattern of Carbonic Anhydrase IX in Medullary Thyroid Carcinoma Supports a Role for RET-Mediated Activation of the HIF Pathway
- (2014) Martina Takacova et al. AMERICAN JOURNAL OF PATHOLOGY
- The cellular response to DNA damage: A focus on MDC1 and its interacting proteins
- (2014) Gideon Coster et al. Nucleus
- featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
- (2013) Y. Liao et al. BIOINFORMATICS
- The genomic landscape of small intestine neuroendocrine tumors
- (2013) Michaela S. Banck et al. JOURNAL OF CLINICAL INVESTIGATION
- Somatic mutation of CDKN1B in small intestine neuroendocrine tumors
- (2013) Joshua M Francis et al. NATURE GENETICS
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Exomic Sequencing of Medullary Thyroid Cancer Reveals Dominant and Mutually Exclusive Oncogenic Mutations inRETandRAS
- (2012) Nishant Agrawal et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Circulating Tumor Cells As Prognostic Markers in Neuroendocrine Tumors
- (2012) Mohid S. Khan et al. JOURNAL OF CLINICAL ONCOLOGY
- wANNOVAR: annotating genetic variants for personal genomes via the web
- (2012) Xiao Chang et al. JOURNAL OF MEDICAL GENETICS
- De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer
- (2012) Xiwei Wu et al. Journal of Translational Medicine
- DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
- (2011) Y. Jiao et al. SCIENCE
- Identification of Unknown Primary Tumors in Patients With Neuroendocrine Liver Metastases
- (2010) Sam C. Wang ARCHIVES OF SURGERY
- mTORC1 Signaling under Hypoxic Conditions Is Controlled by ATM-Dependent Phosphorylation of HIF-1α
- (2010) Hakan Cam et al. MOLECULAR CELL
- The Pathologic Classification of Neuroendocrine Tumors
- (2010) David S. Klimstra et al. PANCREAS
- ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS
- (2010) A. Alexander et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Circos: An information aesthetic for comparative genomics
- (2009) M. Krzywinski et al. GENOME RESEARCH
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More